Apicore was founded by Vithal Dhaduk in 2014.

Who are Apicore's investors?

Apicore's investors include Signet Healthcare Partners.

How much funding has Apicore raised?

Apicore has disclosed $16.8M raised across 4 rounds.

Where is Apicore headquartered?

Apicore is headquartered in Somerset, US.

Apicore

Somerset, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

Apicore was founded in 2014 by Vithal Dhaduk.

Vithal DhadukFounder

Albert FriesenExecutive

Ravishanker KoviExecutive

Board

Theron E. OdlaugBoard directorOperating Partner / Advisor at Signet Healthcare Partners

James GaleBoard directorFounding Partner & Managing Director at Signet Healthcare Partners

Todd SoneBoard director

Vithal DahdukBoard director

Timothy B. SawyerBoard director

Investors · 1

Signet Healthcare PartnersNew York · $10M – $50M

Reported raises · per SEC filings

Form D private placements

$16.8M disclosed across 4 rounds · 2014–2016

▶$720.1KraisedOct 2016 · 4 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Albert FriesenExecutive Officer, Director
Vithal DahdukDirector
Timothy B. SawyerDirector
Ravishanker KoviExecutive Officer, Director
Theron E. OdlaugDirector
James GaleExecutive Officer
Todd SoneDirector

Offering amount: $720.1K
Amount sold: $720.1K
First sale: Sep 2016
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$9.2MraisedJul 2014 · 2 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Todd SoneDirector
Ravishanker KoviExecutive Officer, Director
Vithal DhadukDirector
Albert FriesenExecutive Officer, Director
James GaleExecutive Officer

Offering amount: $9.2M
Amount sold: $9.2M
First sale: Jul 2014
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.8MraisedJul 2014 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

James GaleExecutive Officer
Ravishanker KoviExecutive Officer, Director
Albert FriesenExecutive Officer, Director
Todd SoneDirector
Vithal DhadukDirector

Offering amount: $6.8M
Amount sold: $6.8M
First sale: Jul 2014
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$12.5KraisedJul 2014 · 12 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

James GaleExecutive Officer
Vithal DhadukDirector
Todd SoneDirector
Ravishanker KoviExecutive Officer, Director
Albert FriesenExecutive Officer, Director

Offering amount: $12.5K
Amount sold: $12.5K
First sale: Jul 2014
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Rkpharmainc7 shared keywordsRK Pharma Inc is a US-based generic pharmaceutical group that develops, manufactures, and sells generic drugs, active pharmaceutical ingredients, and injectable, sterile ophthalmic, and dermal products, with a focus on formulation-challenged and first-generic opportunities. It operates through subsidiaries in the US and India, serving the worldwide pharmaceutical industry.

Companies competing with Apicore for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

Who founded Apicore?: Apicore was founded by Vithal Dhaduk in 2014.
Who are Apicore's investors?: Apicore's investors include Signet Healthcare Partners.
How much funding has Apicore raised?: Apicore has disclosed $16.8M raised across 4 rounds.
Where is Apicore headquartered?: Apicore is headquartered in Somerset, US.